Effect of naloxone therapy on depersonalization: A pilot study

Journal of Psychopharmacology

Volumn 15, Issue 2, 2001, Pages 93-95

  Nuller, Y L ^a   Morozova, M G ^a   Kushnir, O N ^a   Hamper, N ^a  

^a Bekhterev St Petersburg Psychoneurological Research Institute   (Russian Federation)

Author keywords

Depersonalization; Glucocorticoids; Naloxone

Indexed keywords

CORTICOSTEROID; CORTICOSTERONE; CORTISONE; HYDROCORTISONE; NALOXONE; OPIATE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID RELEASE; CORTICOSTERONE BLOOD LEVEL; DEPERSONALIZATION; DISEASE SEVERITY; DRUG EFFECT; DRUG INFUSION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; PATHOGENESIS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SINGLE BLIND PROCEDURE;

EID: 0034935330     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110101500205     Document Type: Article

References (14)

1. Unresponsiveness of catatonic symptoms to naloxone
2. Indices of pain threshold as a method of objective assessment of depersonalization therapy efficacy
3. Multiple hormonal responses to morphine: Relationship to diagnosis and dexamethasone suppression
4. Opioid peptide and alpha-adrenoreceptor pathways in the regulation of the pituitary-adrenal axis in man
5. Determination of six corticosteroids in human serum by reversed phase microcolumn HPLC
6. Behavioral effects of opioid receptor antagonists in psychopathological states
7. Behavioral effects of naloxone infusion in obsessive-compulsive disorder
8. Study of pain sensitivity based on the indicators of electroodontometry in patients with depersonalization and depressive disorders
9. Depersonalisazion - Symptoms, meaning, therapy
10. Naloxone and naltrexone in mental illness and tardive dyskinesia